These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Performance of hepatitis B assays on the Bayer ADVIA Centaur Immunoassay System. van Helden J, Denoyel G, Karwowska S, Reamer R, Schmalz J, Wright T, Preisel-Simmons B. Clin Lab; 2004; 50(1-2):63-73. PubMed ID: 15000222 [Abstract] [Full Text] [Related]
3. European performance evaluations of the ADVIA Centaur infectious disease assays: requirements for performance evaluation according to the European directive on in vitro diagnostics. Dati F, Denoyel G, van Helden J. J Clin Virol; 2004 Apr; 30 Suppl 1():S6-10. PubMed ID: 15062761 [Abstract] [Full Text] [Related]
4. Comparison of the ADVIA Centaur and Abbott AxSYM immunoassay systems for a routine diagnostic virology laboratory. Taylor P, Pickard G, Gammie A, Atkins M. J Clin Virol; 2004 Apr; 30 Suppl 1():S11-5. PubMed ID: 15062762 [Abstract] [Full Text] [Related]
15. Detection of HBsAg mutants in a population with a low prevalence of hepatitis B virus infection. Gibb R, Nimmo GR, O'Loughlin P, Lowe P, Drummond D. J Med Virol; 2007 Apr; 79(4):351-5. PubMed ID: 17311336 [Abstract] [Full Text] [Related]
16. Performance of a new HIV 1/O/2 assay on the Bayer ADVIA Centaur immunoassay system. van Helden J, Denoyel G, Freeman J, Preisel-Simmons B. Clin Lab; 2004 Apr; 50(1-2):83-90. PubMed ID: 15000224 [Abstract] [Full Text] [Related]
17. Do we need an 'in-house' neutralization assay for confirmation of hepatitis B surface antigen? Answers from a tertiary care hospital in India. Fletcher GJ, Gnanamony M, David J, Ismail AM, Subramani T, Abraham P. J Gastroenterol Hepatol; 2010 May; 25(5):942-5. PubMed ID: 19929924 [Abstract] [Full Text] [Related]